Korean J Nephrol.
1992 Dec;11(4):386-391.
Clinical trial of recombinant human erythropoietin (Epoetin beta) on hemodialysis patients
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Hemoglobin Variability Associated with Different Erythropoiesis Stimulating Agents in Hemodialysis Patients
- Leukocytoclastic Vasulitis Induced by Methoxy Polyethylene Glycol-Epoetin Beta
- Effects of Adjuvant Androgen on Anemia and Nutritional Parameters in Chronic Hemodialysis Patients Using Low-dose Recombinant Human Erythropoietin
- Acquired Pure Red Cell Aplasia due to Anti-Erythropoietin Antibodies in a Patient Undergoing Hemodialysis
- Effects of recombinant human erythropoietin therapy in hemodialysis patient
